<adaxml xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xsi:noNamespaceSchemaLocation="../ada_schemas/ada_opvragen_potentiele_contraindicaties.xsd">
   <meta status="new"
         created-by="medicatieprocesada"
         last-update-by="medicatieprocesada"
         creation-date="2020-10-28T10:30:23.103+01:00"
         last-update-date="2020-10-28T10:31:41.062+01:00"/>
   <data>
      <opvragen_potentiele_contraindicaties app="mp-mp920"
                                            shortName="opvragen_potentiele_contraindicaties"
                                            formName="afhandelen_medicatievoorschrift_met_references"
                                            transactionRef="2.16.840.1.113883.2.4.3.11.60.20.77.4.70"
                                            transactionEffectiveDate="2013-08-07T00:00:00"
                                            prefix="mp-"
                                            language="nl-NL"
                                            title="MP KWALIFICATIE Afhandelen Voorschrift Scenarioset 3-3-5"
                                            desc="&lt;div&gt;Tweede MVE ivm TA met nieuwe PRK. LET OP: wijziging toedieningsafspraak van scenario 1.2b&lt;/div&gt;"
                                            id="var-Scenarioset3-3-5">
         <scenario-nr value="3.5" conceptId="2.16.840.1.113883.2.4.3.11.999.77.2.4.1.2"/>
         <systeemrol value="1"
                     code="1"
                     codeSystem="2.16.840.1.113883.2.4.3.11.999.77.11.1.19798.5.1.20201207000000"
                     displayName="Beide"
                     conceptId="2.16.840.1.113883.2.4.3.11.999.77.2.4.1.5"/>
         <screenshot value="&lt;div&gt;Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt&lt;/div&gt;"
                     conceptId="2.16.840.1.113883.2.4.3.11.999.77.2.4.1.3"/>
         <patient-id value="999910401"
                     root="2.16.840.1.113883.2.4.6.3"
                     conceptId="2.16.840.1.113883.2.4.3.11.999.77.2.4.1.1"/>
         <toedieningsafspraak comment="" conceptId="2.16.840.1.113883.2.4.3.11.999.77.2.4.294.1">
            <toedieningsafspraak-id value="MBH_920_start_duur2_TA_techstaken"
                                    root="2.16.840.1.113883.2.4.3.11.999.77.422037009.1"
                                    conceptId="2.16.840.1.113883.2.4.3.11.999.77.2.4.294.1.1"/>
         </toedieningsafspraak>
         <toedieningsafspraak comment="" conceptId="2.16.840.1.113883.2.4.3.11.999.77.2.4.294.1">
            <toedieningsafspraak-id value="MBH_920_start_duur2_TA_anderePRK"
                                    root="2.16.840.1.113883.2.4.3.11.999.77.422037009.1"
                                    conceptId="2.16.840.1.113883.2.4.3.11.999.77.2.4.294.1.1"/>
         </toedieningsafspraak>
         <medicatieverstrekking comment="" conceptId="2.16.840.1.113883.2.4.3.11.999.77.2.4.346.1">
            <verstrekking-id value="MBH_920_start_duur2_MVE_anderePRK"
                             root="2.16.840.1.113883.2.4.3.11.999.77.422037009.1"
                             conceptId="2.16.840.1.113883.2.4.3.11.999.77.2.4.346.1.1"/>
         </medicatieverstrekking>
      </opvragen_potentiele_contraindicaties>
   </data>
</adaxml>
